Review Article|Articles in Press

Stereotactic Body Radiation Therapy Versus Ablation Versus Surgery for Early-Stage Lung Cancer in High-Risk Patients

Published:February 26, 2023DOI:


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Thoracic Surgery Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Cancer Society
        Cancer Statistics Center.
        (Available at:) (Accessed June 6, 2022)
        • McGarry R.C.
        • Song G.
        • des Rosiers P.
        • et al.
        Observation-only management of early stage, medically inoperable lung cancer: poor outcome.
        Chest. 2002; 121: 1155-1158
        • Detterbeck F.C.
        • Lewis S.Z.
        • Diekemper R.
        • et al.
        Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2013; 143: 7S-37S
        • Ginsberg R.J.
        • Rubinstein L.V.
        Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.
        Ann Thorac Surg. 1995; 60: 615-623
        • Tsutani Y.
        • Kagimoto A.
        • Handa Y.
        • et al.
        Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy. Japanese journal of clinical oncology.
        (Available at:) (Published December 27, 2019. Accessed July 19, 2022)
        • Tsutani Y.
        • Handa Y.
        • Shimada Y.
        • et al.
        Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery.
        (Available at:) (Published October 22, 2020. Accessed July 19, 2022)
        • Handa Y.
        • Tsutani Y.
        • Mimae T.
        • et al.
        A Multicenter Study of Complex Segmentectomy Versus Wedge Resection in Clinical Stage 0-IA Non-Small Cell Lung Cancer.
        Clin Lung Cancer. 2022; 23: 393-401
        • El-Sherif A.
        • Fernando H.C.
        • Santos R.
        • et al.
        Margin and local recurrence after sublobar resection of non-small cell lung cancer.
        Ann Surg Oncol. 2007; 14: 2400-2405
        • Sawabata N.
        • Matsumura A.
        • Ohota M.
        • et al.
        Cytologically malignant margins of wedge resected stage I non-small cell lung cancer.
        Ann Thorac Surg. 2002; 74: 1953-1957
        • Schuchert M.J.
        • Pettiford B.L.
        • Keeley S.
        • et al.
        Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.
        Ann Thorac Surg. 2007; 84: 926-933
        • Ball D.
        • Mai G.T.
        • Vinod S.
        • et al.
        Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
        Lancet Oncol. 2019; 20: 494-503
        • Macià I Garau M.
        Radiobiology of stereotactic body radiation therapy (SBRT).
        Rep Pract Oncol Radiother. 2017; 22: 86-95
        • Onishi H.
        • Araki T.
        • Shirato H.
        • et al.
        Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study.
        Cancer. 2004; 101: 1623-1631
        • Lammers A.
        • Mitin T.
        • Moghanaki D.
        • et al.
        Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey.
        Adv Radiat Oncol. 2018; 3: 125-129
        • Palma D.A.
        • Nguyen T.K.
        • Louie A.V.
        • et al.
        Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
        JAMA Oncol. 2019; 5: 681-688
        • Mayne N.R.
        • Lin B.K.
        • Darling A.J.
        • et al.
        Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer.
        Ann Surg. 2020; 272: 925-929
        • Chang J.Y.
        • Senan S.
        • Paul M.A.
        • et al.
        Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.
        Lancet Oncol. 2015; 16 ([published correction appears in Lancet Oncol. 2015 Sep;16(9):e427]): 630-637
        • Cameron R.
        • Gage D.
        Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy Trial (VALOR). identifier: NCT02984761.
        (Available at:) (Updated March 21, 2022. Accessed July 19, 2022)
        • Teke M.E.
        • Sarvestani A.L.
        • Hernandez J.M.
        • et al.
        A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).
        Ann Surg Oncol. 2022; 29: 4686-4687
        • Thibault I.
        • Chiang A.
        • Erler D.
        • et al.
        Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.
        Clin Oncol. 2016; 28: 28-35
        • Barriger R.B.
        • Forquer J.A.
        • Brabham J.G.
        • et al.
        A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
        Int J Radiat Oncol Biol Phys. 2012; 82: 457-462
        • Ridge C.A.
        • Solomon S.B.
        • Thornton R.H.
        Thermal ablation of stage I non-small cell lung carcinoma.
        Semin Intervent Radiol. 2014; 31: 118-124
        • Gillams A.R.
        • Lees W.R.
        Radiofrequency ablation of lung metastases: factors influencing success.
        Eur Radiol. 2008; 18: 672-677
        • Dupuy D.E.
        • Fernando H.C.
        • Hillman S.
        • et al.
        Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.
        Cancer. 2015; 121: 3491-3498
        • Li M.
        • Xu X.
        • Qin Y.
        • et al.
        Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients.
        J Cancer. 2021; 12: 3057-3066
        • Lencioni R.
        • Crocetti L.
        • Cioni R.
        • et al.
        Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).
        Lancet Oncol. 2008; 9: 621-628
        • Yu J.
        • Yu X.L.
        • Han Z.Y.
        • et al.
        Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial.
        Gut. 2017; 66: 1172-1173
        • Ni Y.
        • Huang G.
        • Yang X.
        • et al.
        Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results.
        Eur Radiol. 2022; 32: 5616-5622
        • Whittaker D.K.
        Mechanisms of tissue destruction following cryosurgery.
        Ann R Coll Surg Engl. 1984; 66: 313-318
        • Inoue M.
        • Nakatsuka S.
        • Yashiro H.
        • et al.
        Percutaneous cryoablation of lung tumors: feasibility and safety.
        J Vasc Interv Radiol. 2012; 23: 295-305
        • Moore W.
        • Talati R.
        • Bhattacharji P.
        • et al.
        Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients.
        J Vasc Interv Radiol. 2015; 26: 312-319
        • Li H.W.
        • Long Y.J.
        • Yan G.W.
        • et al.
        Microwave ablation vs. cryoablation for treatment of primary and metastatic pulmonary malignant tumors.
        Mol Clin Oncol. 2022; 16: 62
        • Chan J.W.Y.
        • Lau R.W.H.
        • Chang A.
        • et al.
        Transbronchial Microwave Ablation – Important Role in the Battle of Lung Preservation for Multifocal Lung Primaries or Metastases.
        Ann Oncol. April. 2022; 33: S76-S77
        • Ishiwata T.
        • Motooka Y.
        • Ujiie H.
        • et al.
        Endobronchial ultrasound-guided bipolar radiofrequency ablation for lung cancer: A first-in-human clinical trial [published online ahead of print, 2022 Mar 26].
        J Thorac Cardiovasc Surg. 2022; S0022-5223: 00344-350
        • Chan J.W.Y.
        • Lau R.W.H.
        • Ngai J.C.L.
        • et al.
        Transbronchial microwave ablation of lung nodules with electromagnetic navigation bronchoscopy guidance-a novel technique and initial experience with 30 cases.
        Transl Lung Cancer Res. 2021; 10: 1608-1622
        • Lau K.
        • Lau R.
        • Baranowski R.
        • et al.
        Late breaking abstract - bronchoscopic microwave ablation of peripheral lung tumors. European Respiratory Society.
        (Available at:) (Published September 5, 2021)
        • Sun J.
        Transbronchial Ablation for Peripheral Lung Tumor. identifier: NCT02972177.
        (Available at:) (Updated February 18,2020. Accessed July 2, 2022)
        • Dong B.
        • Wang J.
        • Xu Y.
        • et al.
        Comparison of the Efficacy of Stereotactic Body Radiotherapy versus Surgical Treatment for Early-Stage Non-Small Cell Lung Cancer after Propensity Score Matching.
        Transl Oncol. 2019; 12: 1032-1037
        • Detillon D.D.E.M.A.
        • Aarts M.J.
        • De Jaeger K.
        • et al.
        Video-assisted thoracic lobectomy versus stereotactic body radiotherapy for stage I nonsmall cell lung cancer in elderly patients: a propensity matched comparative analysis.
        Eur Respir J. 2019; 53: 1801561
        • Cornwell L.D.
        • Echeverria A.E.
        • Samuelian J.
        • et al.
        Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
        J Thorac Cardiovasc Surg. 2018; 155: 395-402
        • Lin Q.
        • Sun X.
        • Zhou N.
        • et al.
        Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis.
        BMC Pulm Med. 2019; 19: 98
        • Hamaji M.
        • Chen F.
        • Matsuo Y.
        • et al.
        Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
        Ann Thorac Surg. 2015; 99: 1122-1129
        • Kawamura M.
        • Izumi Y.
        • Tsukada N.
        • et al.
        Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates.
        J Thorac Cardiovasc Surg. 2006; 131: 1007-1013
        • Yamauchi Y.
        • Izumi Y.
        • Hashimoto K.
        • et al.
        Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer.
        PLoS One. 2012; 7: e33223
        • Healey T.T.
        • March B.T.
        • Baird G.
        • et al.
        Microwave Ablation for Lung Neoplasms: A Retrospective Analysis of Long-Term Results.
        J Vasc Interv Radiol. 2017; 28: 206-211
        • Yang X.
        • Ye X.
        • Zheng A.
        • et al.
        Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases.
        J Surg Oncol. 2014; 110: 758-763
        • Palussière J.
        • Chomy F.
        • Savina M.
        • et al.
        Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial.
        J Cardiothorac Surg. 2018; 13: 91
        • Simon C.J.
        • Dupuy D.E.
        • DiPetrillo T.A.
        • et al.
        Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
        Radiology. 2007; 243: 268-275